Article
KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
Pathology - 1 Jun 2017
Trisolini Elena, Armellini Elia, Paganotti Alessia, Veggiani Claudia, Bozzola Cristina, Frattini Milo, Pizio Corinna, Mancuso Giuseppe, Andorno Silvano, Boldorini Renzo
Abstract excerpt
Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the procedure of choice for the cytologic diagnosis of pancreatic masses. The specificity of EUS-FNA approaches 100%, but the sensitivity is still low, and the high rate of indeterminate (atypical and suspicious) and false-negative results needs improvement. KRAS gene is frequently mutated in pancreatic ductal adenocarcinoma (PDAC) (up to 90%), and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
